Kala Pharmaceuticals, Inc. (22) | Business Finance (6)
Browse by Subcategory
Recent Contracts
-
Asset Purchase Agreement, by and between Kala Pharmaceuticals, Inc., Alcon Pharmaceuticals Ltd. and Alcon Vision, LLC
(Filed With SEC on May 23, 2022)
-
Loan and Security Agreement, dated May 4, 2021, by and among Kala Pharmaceuticals, Inc. and Oxford Finance LLC, as collateral agent and lender
(Filed With SEC on May 5, 2021)
-
Third Amended and Restated Registration Rights Agreement of the Registrant dated April 4, 2016, as amended by Amendment No. 1 dated December 13, 2017, of the Registrant
(Filed With SEC on February 25, 2021)
-
Underwriting Agreement, dated March 10, 2020, by and among Kala Pharmaceuticals, Inc., J.P. Morgan Securities LLC, BofA Securities, Inc. and Jefferies LLC, as representatives of...
(Filed With SEC on March 12, 2020)
-
Amended and Restated 2017 Employee Stock Purchase Plan
(Filed With SEC on May 9, 2019)
-
Amended and Restated 2017 Employee Stock Purchase Plan
(Filed With SEC on March 12, 2019)